USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cochlear Limited

USPTO PatentsView assignee record - 768 granted patents across 57 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04R (LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

768

Total patents granted

CPC technology areas

23.5

Avg claims per patent

+14%

5-year filing velocity

The verdict

Cochlear holds 768 US patents across 57 technology areas, rank #586 of 50,000 tracked assignees.

#586
of 50,000 US assignees by volume: Top 1%
by Innovation Score (68.4/100): 23.5
avg claims per patent: +14%
filing velocity, last 5 yrs

Portfolio overview

Cochlear Limited has been granted 768 US utility patents between 2015 and 2025, placing Cochlear Limited at rank #586 across all assignees tracked by PlainPatent. This portfolio spans 57 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.5 claims per patent with primary concentration in H04R (LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS). As a Foreign Corporation, Cochlear Limited is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Cochlear sits between Axis AB (769 patents, rank #582) and Pacesetter, Inc. (754 patents, rank #590) - the closest US assignees by grant volume. The composite Innovation Score of 68.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 409 grants, compared with 359 in the 2015–2019 window, a +14% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cochlear Limited's 23.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 57 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cochlear Limited against peers pursuing similar technology classes.

Axis AB

769
Globalfoundries S…

769
Janssen Pharmaceu…

769
Medtronic Minimed

769
Cochlear ◀

768
Mellanox

766
Mediatek Singapor…

761
Hanon Systems

758
Pacesetter

754

What this shows Cochlear holds 768 patents at rank #586, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cochlear

By rank, the assignees closest to #586 in granted patent volume.

Leaders in H04R (Loudspeakers)

Other assignees with the most granted patents in Cochlear's primary technology class.

Cochlear's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

68 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cochlear Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	74	9.6%
2016	55	7.2%
2017	67	8.7%
2018	77	10.0%
2019	86	11.2%
2020	81	10.5%
2021	59	7.7%
2022	63	8.2%
2023	69	9.0%
2024	85	11.1%
2025	52	6.8%

Which technologies does Cochlear Limited patent most?

H04R - LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS 520

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 449

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 100

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 78

G10L - SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING 35

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 28

H02J - CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY 26

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 22

H04B - TRANSMISSION 16

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 15

H03G - CONTROL OF AMPLIFICATION 13

G06F - ELECTRIC DIGITAL DATA PROCESSING 11

H04S - STEREOPHONIC SYSTEMS 10

H04M - TELEPHONIC COMMUNICATION 8

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES 7

Top 15 of 57 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Growing

Where it ranks

Overall rank by patents

#586

Across all tracked assignees

Innovation Score

68.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cochlear Limited hold?

Cochlear Limited holds 768 US granted patents filed between 2015 and 2025, spanning 57 technology areas.

What is Cochlear Limited's Innovation Score?

Cochlear Limited has an Innovation Score of 68.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cochlear Limited focus on?

Cochlear Limited's top technology area is H04R (LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS) with 520 patents. The company has filed patents in 57 CPC subclasses total.

Is Cochlear Limited's patent filing rate increasing or decreasing?

Cochlear Limited's recent filing velocity is +14% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Cochlear Limited's patents?

Cochlear Limited's patents average 23.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Cochlear Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cochlear's 768 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cochlear ranks #586 of 50,000. Top 50 holders
Most of this portfolio concentrates in H04R - see who else leads that technology area. H04R leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.